Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 28Breast Neoplasms 17Colorectal Neoplasms 14Prostatic Neoplasms 13Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 6Leukemia 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Pancreatic Neoplasms 4Lymphoma 4Endometrial Neoplasms 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Genetic Predisposition to Disease 3Disease 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Low Anterior Resection Syndrome 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Arthritis, Reactive × Interviews as Topic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡